Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort
- PMID: 26914911
- PMCID: PMC4770858
- DOI: 10.1097/QAI.0000000000000894
Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort
Abstract
Introduction: The disease spectrum for HIV-infected individuals has shifted toward comorbid non-AIDS conditions including chronic lung disease, but quantitative image analysis of lung disease has not been performed.
Objectives: To quantify the prevalence of structural changes of the lung indicating emphysema or fibrosis on radiographic examination.
Methods: A cross-sectional analysis of 510 HIV-infected participants in the multicenter Lung-HIV study was performed. Data collected included demographics, biological markers of HIV, pulmonary function testing, and chest computed tomographic examinations. Emphysema and fibrosis-like changes were quantified on computed tomographic images based on threshold approaches.
Results: In our cohort, 69% was on antiretroviral therapy, 13% had a current CD4 cell count less than 200 cells per microliter, 39% had an HIV viral load greater than 500 copies per milliliter, and 25% had at least a trace level of emphysema (defined as >2.5% of voxels <-950HU). Trace emphysema was significantly correlated with age, smoking, and pulmonary function. Neither current CD4 cell count nor HIV viral load was significantly correlated with emphysema. Fibrosis-like changes were detected in 29% of the participants and were significantly correlated with HIV viral load (Pearson correlation coefficient = 0.210; P < 0.05); current CD4 cell count was not associated with fibrosis. In multivariable analyses including age, race, and smoking status, HIV viral load remained significantly correlated with fibrosis-like changes (coefficient = 0.107; P = 0.03).
Conclusions: A higher HIV viral load was significantly associated with fibrosis-like changes, possibly indicating early interstitial lung disease, but emphysematous changes were not related to current CD4 cell count or HIV viral load.
Conflict of interest statement
Similar articles
-
A Low Peripheral Blood CD4/CD8 Ratio Is Associated with Pulmonary Emphysema in HIV.PLoS One. 2017 Jan 25;12(1):e0170857. doi: 10.1371/journal.pone.0170857. eCollection 2017. PLoS One. 2017. PMID: 28122034 Free PMC article.
-
Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: implications for lung cancer screening.AIDS. 2017 Jul 31;31(12):1715-1720. doi: 10.1097/QAD.0000000000001529. AIDS. 2017. PMID: 28463881 Free PMC article.
-
Chest computed tomography findings in HIV-infected individuals in the era of antiretroviral therapy.PLoS One. 2014 Nov 19;9(11):e112237. doi: 10.1371/journal.pone.0112237. eCollection 2014. PLoS One. 2014. PMID: 25409510 Free PMC article.
-
[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Enferm Infecc Microbiol Clin. 2009. PMID: 19246124 Spanish.
-
[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Enferm Infecc Microbiol Clin. 2011. PMID: 21388714 Spanish.
Cited by
-
Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection.Front Immunol. 2022 Jan 4;12:808722. doi: 10.3389/fimmu.2021.808722. eCollection 2021. Front Immunol. 2022. PMID: 35058937 Free PMC article. Review.
-
Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.HIV Med. 2019 Mar;20(3):192-201. doi: 10.1111/hiv.12699. Epub 2019 Jan 8. HIV Med. 2019. PMID: 30620136 Free PMC article.
-
Neglected mycobiome in HIV infection: Alterations, common fungal diseases and antifungal immunity.Front Immunol. 2022 Nov 10;13:1015775. doi: 10.3389/fimmu.2022.1015775. eCollection 2022. Front Immunol. 2022. PMID: 36439143 Free PMC article. Review.
-
The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view.Biomedicines. 2024 Mar 13;12(3):639. doi: 10.3390/biomedicines12030639. Biomedicines. 2024. PMID: 38540252 Free PMC article. Review.
-
Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.AIDS. 2018 Jan 28;32(3):277-292. doi: 10.1097/QAD.0000000000001712. AIDS. 2018. PMID: 29194119 Free PMC article. Review.
References
-
- Cohen BA, Pomeranz S, Rabinowitz JG, et al. Pulmonary complications of AIDS: radiologic features. AJR Am J Roentgenol. 1984 Jul;143(1):115–122. - PubMed
-
- Kuhlman JE, Fishman EK, Hruban RH, Knowles M, Zerhouni EA, Siegelman SS. Diseases of the chest in AIDS: CT diagnosis. Radiographics. 1989 Sep;9(5):827–857. - PubMed
-
- Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1356–1372. - PubMed
-
- Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part II. Am Rev Respir Dis. 1990 Jun;141(6):1582–1598. - PubMed
-
- Braithwaite RS, Justice AC, Chang CC, et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med. 2005 Aug;118(8):890–898. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HL121814/HL/NHLBI NIH HHS/United States
- U01 AI035042/AI/NIAID NIH HHS/United States
- U01 DA036297/DA/NIDA NIH HHS/United States
- R01-HL090316/HL/NHLBI NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- U01-AI-35043/AI/NIAID NIH HHS/United States
- R01 HL090483/HL/NHLBI NIH HHS/United States
- U01-AI-35042/AI/NIAID NIH HHS/United States
- U01-AI-42590/AI/NIAID NIH HHS/United States
- UL1 RR024153/RR/NCRR NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- R01-HL126549/HL/NHLBI NIH HHS/United States
- K24-HL087713/HL/NHLBI NIH HHS/United States
- R01-HL090339/HL/NHLBI NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- R01 HL090342/HL/NHLBI NIH HHS/United States
- R01-HL090331/HL/NHLBI NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U01-HL121814/HL/NHLBI NIH HHS/United States
- R01 HL090316/HL/NHLBI NIH HHS/United States
- UL1TR000005/TR/NCATS NIH HHS/United States
- U01-AI-35041/AI/NIAID NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- R01-HL090342/HL/NHLBI NIH HHS/United States
- UM1 AI035043/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- R01 HL090331/HL/NHLBI NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- K24 HL087713/HL/NHLBI NIH HHS/United States
- R01 HL090313/HL/NHLBI NIH HHS/United States
- R01-HL090335/HL/NHLBI NIH HHS/United States
- UL1-RR025005/RR/NCRR NIH HHS/United States
- U01-AI-35040/AI/NIAID NIH HHS/United States
- R01 HL090339/HL/NHLBI NIH HHS/United States
- UL1TR000004/TR/NCATS NIH HHS/United States
- K24 AI118591/AI/NIAID NIH HHS/United States
- R01 HL090335/HL/NHLBI NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- R01-HL125432/HL/NHLBI NIH HHS/United States
- R01 DA012568/DA/NIDA NIH HHS/United States
- U01-AI-35039/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- R01 HL125432/HL/NHLBI NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 HL121819/HL/NHLBI NIH HHS/United States
- R01-HL090313/HL/NHLBI NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- R01 HL126549/HL/NHLBI NIH HHS/United States
- U01-AI-34989/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials